5,148 Shares in Balchem Corporation (NASDAQ:BCPC) Acquired by XTX Topco Ltd

XTX Topco Ltd bought a new stake in shares of Balchem Corporation (NASDAQ:BCPC - Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 5,148 shares of the basic materials company's stock, valued at approximately $855,000.

Several other institutional investors and hedge funds have also recently modified their holdings of BCPC. GAMMA Investing LLC increased its position in Balchem by 20,231.2% during the first quarter. GAMMA Investing LLC now owns 177,288 shares of the basic materials company's stock valued at $29,430,000 after acquiring an additional 176,416 shares during the last quarter. Bank of America Corp DE boosted its holdings in shares of Balchem by 120.9% in the fourth quarter. Bank of America Corp DE now owns 156,562 shares of the basic materials company's stock valued at $25,519,000 after purchasing an additional 85,692 shares during the period. FMR LLC increased its stake in shares of Balchem by 16.0% during the fourth quarter. FMR LLC now owns 576,994 shares of the basic materials company's stock valued at $94,047,000 after buying an additional 79,499 shares during the period. BNP Paribas Financial Markets increased its position in Balchem by 283.1% during the 4th quarter. BNP Paribas Financial Markets now owns 81,805 shares of the basic materials company's stock valued at $13,334,000 after purchasing an additional 60,449 shares during the period. Finally, Assenagon Asset Management S.A. boosted its stake in shares of Balchem by 343.2% during the first quarter. Assenagon Asset Management S.A. now owns 66,309 shares of the basic materials company's stock valued at $11,007,000 after purchasing an additional 51,348 shares in the last quarter. Institutional investors own 87.91% of the company's stock.

Balchem Stock Performance

Shares of BCPC stock traded down $1.59 during trading hours on Thursday, hitting $158.41. The company's stock had a trading volume of 104,542 shares, compared to its average volume of 167,385. The company has a current ratio of 2.64, a quick ratio of 1.57 and a debt-to-equity ratio of 0.17. The company has a 50 day moving average of $159.43 and a 200 day moving average of $162.16. Balchem Corporation has a 12-month low of $145.70 and a 12-month high of $185.96. The stock has a market cap of $5.14 billion, a PE ratio of 36.35, a price-to-earnings-growth ratio of 3.34 and a beta of 0.88.

Balchem (NASDAQ:BCPC - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The basic materials company reported $1.27 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.25 by $0.02. The company had revenue of $255.47 million during the quarter, compared to the consensus estimate of $250.31 million. Balchem had a return on equity of 12.41% and a net margin of 14.48%. Balchem's revenue for the quarter was up 9.1% on a year-over-year basis. During the same period in the previous year, the company posted $1.09 earnings per share. On average, sell-side analysts forecast that Balchem Corporation will post 4.64 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on BCPC shares. HC Wainwright raised their price objective on Balchem from $180.00 to $189.00 and gave the company a "buy" rating in a research report on Monday. Wall Street Zen cut Balchem from a "buy" rating to a "hold" rating in a research note on Saturday, July 26th.

Balchem Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.